Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Case Report
Abstract
Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 is characterized by hypercytokinemia leading to overwhelming inflammation. We describe the use of a hemadsorption device as part of the supportive treatment for cytokine storm.
Keywords
Hemoadsorption; Inflammatory multisystemic syndrome; Myocardial injury; Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV
Bibliographic citation
Ruiz-Rodríguez JC, Chiscano-Camón L, Palmada C, Ruiz-Sanmartin A, García-de-Acilu M, Plata-Menchaca E, et al. Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Case Report. Front Immunol. 2021 Jun;12:665824.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/7073This item appears in following collections
- Col·lecció especial COVID-19 [860]
- HVH - Articles científics [2469]
- VHIR - Articles científics [1003]
The following license files are associated with this item: